136 related articles for article (PubMed ID: 38423040)
1. Harnessing stereotactic precision in the fight against primary kidney cancer: time for a randomised trial?
Yang DX; Hannan R
Lancet Oncol; 2024 Mar; 25(3):267-269. PubMed ID: 38423040
[No Abstract] [Full Text] [Related]
2. Image guidance and stabilization for stereotactic ablative body radiation therapy (SABR) treatment of primary kidney cancer.
Pham D; Kron T; Bressel M; Foroudi F; Hardcastle N; Schneider M; Soteriou S; Innes J; Siva S
Pract Radiat Oncol; 2015; 5(6):e597-605. PubMed ID: 26547828
[TBL] [Abstract][Full Text] [Related]
3. Inoperable primary renal cancer--stereotactic radiosurgery viable choice.
Oncology (Williston Park); 2012 Dec; 26(12):1212, 1214. PubMed ID: 23413604
[No Abstract] [Full Text] [Related]
4. Stereotactic ablative body radiotherapy for primary kidney cancer: what have we learned from prospective trials and what does the future hold?
Siva S; Daniels CP; Ellis RJ; Ponsky L; Lo SS
Future Oncol; 2016 Mar; 12(5):601-6. PubMed ID: 26837548
[No Abstract] [Full Text] [Related]
5. Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trial.
Siva S; Bressel M; Sidhom M; Sridharan S; Vanneste BGL; Davey R; Montgomery R; Ruben J; Foroudi F; Higgs B; Lin C; Raman A; Hardcastle N; Hofman MS; De Abreu Lourenco R; Shaw M; Mancuso P; Moon D; Wong LM; Lawrentschuk N; Wood S; Brook NR; Kron T; Martin J; Pryor D;
Lancet Oncol; 2024 Mar; 25(3):308-316. PubMed ID: 38423047
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic ablative body radiation therapy for primary kidney cancer: a 3-dimensional conformal technique associated with low rates of early toxicity.
Pham D; Thompson A; Kron T; Foroudi F; Kolsky MS; Devereux T; Lim A; Siva S
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1061-8. PubMed ID: 25442039
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic body radiotherapy for primary renal cell carcinoma: a systematic review and practice guideline from the International Society of Stereotactic Radiosurgery (ISRS).
Siva S; Louie AV; Kotecha R; Barber MN; Ali M; Zhang Z; Guckenberger M; Kim MS; Scorsetti M; Tree AC; Slotman BJ; Sahgal A; Lo SS
Lancet Oncol; 2024 Jan; 25(1):e18-e28. PubMed ID: 38181809
[TBL] [Abstract][Full Text] [Related]
8. Editorial Comment: The Emerging Role of Stereotactic Ablative Radiotherapy for Primary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
Zequi SC
Int Braz J Urol; 2020; 46(3):473. PubMed ID: 32167721
[No Abstract] [Full Text] [Related]
9. Stereotactic Radiotherapy for Oligoprogressive Disease: A New Frontier in Kidney Cancer.
Siva S; Ost P; Zaorsky N; Staehler M
Eur Urol; 2021 Dec; 80(6):701-702. PubMed ID: 34563413
[No Abstract] [Full Text] [Related]
10. Personalising treatment plan quality review with knowledge-based planning in the TROG 15.03 trial for stereotactic ablative body radiotherapy in primary kidney cancer.
Hardcastle N; Cook O; Ray X; Moore A; Moore KL; Pryor D; Rossi A; Foroudi F; Kron T; Siva S
Radiat Oncol; 2021 Aug; 16(1):142. PubMed ID: 34344402
[TBL] [Abstract][Full Text] [Related]
11. Editorial Comment to Stereotactic body radiation therapy for kidney cancer. Where do we stand?
Goto Y
Int J Urol; 2023 May; 30(5):445-446. PubMed ID: 36852924
[No Abstract] [Full Text] [Related]
12. Pooled analysis of stereotactic ablative radiotherapy for primary renal cell carcinoma: A report from the International Radiosurgery Oncology Consortium for Kidney (IROCK).
Siva S; Louie AV; Warner A; Muacevic A; Gandhidasan S; Ponsky L; Ellis R; Kaplan I; Mahadevan A; Chu W; Swaminath A; Onishi H; Teh B; Correa RJ; Lo SS; Staehler M
Cancer; 2018 Mar; 124(5):934-942. PubMed ID: 29266183
[TBL] [Abstract][Full Text] [Related]
13. Assessing the impact of renal artery clamping during laparoscopic partial nephrectomy (LPN) for small renal masses: the rationale and design of the CLamp vs Off Clamp Kidney during LPN (CLOCK II) randomised phase III trial.
Bove P; Bertolo R; Sandri M; Farullo G; Cipriani C; Leonardo C; Parma P; Falsaperla M; Veneziano D; Celia A; Minervini A; Antonelli A;
BJU Int; 2019 Sep; 124(3):365-367. PubMed ID: 31009140
[No Abstract] [Full Text] [Related]
14. Using Stereotactic Body Radiotherapy to Overcome the Radioresistant Reputation of Renal Cell Carcinoma.
Nguyen PL
Eur Urol Oncol; 2019 Sep; 2(5):524-525. PubMed ID: 31444135
[No Abstract] [Full Text] [Related]
15. Stereotactic Body Radiation Therapy for Stage I Renal Carcinoma: An Option for Selected Patients.
Read PW
J Vasc Interv Radiol; 2020 Apr; 31(4):574-575. PubMed ID: 32200941
[No Abstract] [Full Text] [Related]
16. Renal Cancer is Not Radioresistant: Slowly but Continuing Shrinkage of the Tumor After Stereotactic Body Radiation Therapy.
Funayama S; Onishi H; Kuriyama K; Komiyama T; Marino K; Araya M; Saito R; Aoki S; Maehata Y; Nonaka H; Tominaga L; Muramatsu J; Nakagomi H; Kamiyama M; Takeda M
Technol Cancer Res Treat; 2019 Jan; 18():1533033818822329. PubMed ID: 30803362
[TBL] [Abstract][Full Text] [Related]
17. Renal cell carcinoma treated with stereotactic radiotherapy with histological change confirmed on autopsy: a case report.
Onishi H; Kawasaki T; Zakoji H; Yoshida T; Komiyama T; Kuriyama K; Araya M; Saito R; Aoki S; Maehata Y; Tominaga L; Marino K; Watanabe I; Oguri M; Araki T; Enomoto N; Takeda M; Katoh R
BMC Res Notes; 2014 Apr; 7():270. PubMed ID: 24767701
[TBL] [Abstract][Full Text] [Related]
18. Preoperative stereotactic body radiotherapy combined with surgical treatment for renal cell carcinoma and inferior vena cava tumour thrombus: study protocol for a single-arm cohort trial.
Liu Y; Liu Z; Peng R; Xiao R; Wang J; Wang H; Ma L
BMJ Open; 2022 Jan; 12(1):e055364. PubMed ID: 35105644
[TBL] [Abstract][Full Text] [Related]
19. Renal hypothermia during partial nephrectomy for patients with renal tumours: a randomised controlled clinical trial protocol.
Breau RH; Cagiannos I; Knoll G; Morash C; Cnossen S; Lavallée LT; Mallick R; Finelli A; Jewett M; Leibovich BC; Cook J; LeBel L; Kapoor A; Pouliot F; Izawa J; Rendon R; Fergusson DA
BMJ Open; 2019 Jan; 9(1):e025662. PubMed ID: 30610026
[TBL] [Abstract][Full Text] [Related]
20. The Role of Stereotactic Ablative Body Radiotherapy in Renal Cell Carcinoma.
Ali M; Mooi J; Lawrentschuk N; McKay RR; Hannan R; Lo SS; Hall WA; Siva S
Eur Urol; 2022 Dec; 82(6):613-622. PubMed ID: 35843777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
